Showing results (351-360 of 464) with videos related to

Sort By:
Pageof 47
Cancer Biology & Therapy|February 21, 2014
Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular modelChunsheng Li, Ann-Marie Chacko, Jia Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancerM J Fisher, A K Virmani, L Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)Junaid Abdulghani, Prashanth Gokare, Jean-Nicolas Gallant, et al.
Frontiers in Pharmacology|December 17, 2021
Therapeutic Targeting of Autophagy in Pancreatic Ductal AdenocarcinomaAlexander G Raufi, Nicholas R Liguori, Lindsey Carlsen, et al.
Cancer Research|February 15, 2015
Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10Joshua E Allen, Varun V Prabhu, Mala Talekar, et al.
American Journal of Cancer Research|January 8, 2024
Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumorsWen-I Chang, Joshua N Honeyman, Jun Zhang, et al.
Oncogene|August 6, 1999
The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tractM S Sheikh, Y Huang, E A Fernandez-Salas, et al.
Cancer Research|March 1, 1994
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosisW S el-Deiry, J W Harper, P M O'Connor, et al.
Cancer Biology & Therapy|March 26, 2015
Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutationAvisnata Das, Miriam Kunkel, Jamal Joudeh, et al.
Oncotarget|November 22, 2017
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancersMohamed E Salem, Benjamin A Weinberg, Joanne Xiu, et al.
Pageof 47